Works matching IS 10600280 AND DT 2015 AND VI 49 AND IP 5
Results: 16
Ombitasvir/paritaprevir/ritonavir and dasabuvir tablets for hepatitis C virus genotype 1 infection.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Corrigendum.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 5, p. 616, doi. 10.1177/1060028015580345
- Publication type:
- Article
Metoclopramide-Induced Asystolic Cardiac Arrest.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 5, p. 610, doi. 10.1177/1060028015577446
- By:
- Publication type:
- Article
New-Onset Atrial Fibrillation Is an Independent Predictor of Mortality in Medical Intensive Care Unit Patients.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 5, p. 523, doi. 10.1177/1060028015574726
- By:
- Publication type:
- Article
Empagliflozin, an SGLT2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus: A Review of the Evidence.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 5, p. 582, doi. 10.1177/1060028015573564
- By:
- Publication type:
- Article
Comparing Fracture Absolute Risk Assessment (FARA) Tools: An Osteoporosis Clinical Informatics Tool to Improve Identification and Care of Men at High Risk of First Fracture.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 5, p. 506, doi. 10.1177/1060028015572819
- By:
- Publication type:
- Article
Comment: Clinical Experience With Prophylactic Fondaparinux in Critically Ill Patients With Moderate to Severe Renal Impairment or Renal Failure Requiring Renal Replacement Therapy.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 5, p. 612, doi. 10.1177/1060028015571726
- By:
- Publication type:
- Article
Reply: Clinical Experience With Prophylactic Fondaparinux in Critically Ill Patients With Moderate to Severe Renal Impairment or Renal Failure Requiring Renal Replacement Therapy.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 5, p. 614, doi. 10.1177/1060028015571658
- By:
- Publication type:
- Article
Vorapaxar in Atherosclerotic Disease Management.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 5, p. 599, doi. 10.1177/1060028015571410
- By:
- Publication type:
- Article
Vancomycin Loading Doses: A Systematic Review.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 5, p. 557, doi. 10.1177/1060028015571163
- By:
- Publication type:
- Article
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Tablets for Hepatitis C Virus Genotype 1 Infection.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 5, p. 566, doi. 10.1177/1060028015570729
- By:
- Publication type:
- Article
Akathisia With Azithromycin.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 5, p. 609, doi. 10.1177/1060028015570728
- By:
- Publication type:
- Article
Patient Preferences for a Polypill for the Prevention of Cardiovascular Diseases.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 5, p. 528, doi. 10.1177/1060028015570468
- By:
- Publication type:
- Article
Adjunctive Intraventricular Antibiotic Therapy for Bacterial Central Nervous System Infections in Critically Ill Patients With Traumatic Brain Injury.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 5, p. 515, doi. 10.1177/1060028015570466
- By:
- Publication type:
- Article
Myxedema Madness: A Case for Short-Term Antipsychotics?
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 5, p. 607, doi. 10.1177/1060028015570089
- By:
- Publication type:
- Article
Pharmacologic Treatment of Type 2 Diabetes: Oral Medications.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 5, p. 540, doi. 10.1177/1060028014558289
- By:
- Publication type:
- Article